About Male Infertility
Infertility is a widespread problem. In male infertility, the male fails to impregnate his female partner after a year of unprotected sex. Male infertility is due to a couple of factors including:
• Low sperm production
• Abnormal sperm function or
• Blockages that prevent the delivery of sperm.
Hormonal disturbances to physical problems, or psychological problems can cause male infertility. In most cases, there are no obvious sign or symptoms of an infertility problem. 20 percent of the total infertility is due to male factors. Despite of the scarcity of medicines to treat male infertility, many successful treatment options exist for its many causes.
TechNavio's analysts forecast the Global Male Infertility market to grow at a CAGR of 6.60 percent over the period 2014-2019.
Covered in this Report
The Global Male Infertility market can be divided into seven segments: DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Penetration Assay, Sperm Agglutination, CASA, and Others. This report covers the present scenario and the growth prospects of the Global Male Infertility market for the period 2014–2019. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests and equipment's used in the treatment of male infertility that are available in the market.
TechNavio's report, the Global Male Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Male Infertility market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• CooperSurgical Inc
• Elelixis Diagnostics SA
• Halotech DNA SL
• Medical Electronic Systems LLC
Market Driver
• Increase in Aging Population
• For a full, detailed list, view our report.
Market Challenge
• High Cost
• For a full, detailed list, view our report.
Market Trend
• Increase in Awareness
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Disease Overview
05.1 Male Infertility
05.1.1 Etiology
05.1.2 Signs and Symptoms
05.1.3 Treatment
05.1.4 Diagnosis
06. Introduction
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Technology
09. Geographical Segmentation
09.1 Male Infertility Market in Americas
09.1.1 Market Size and Forecast
09.2 Male Infertility Market in the EMEA Region
09.2.1 Market Size and Forecast
09.3 Male Infertility Market in the APAC Region
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
18. Key Vendor Analysis
18.1 CooperSurgical Inc
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Product Portfolio by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
18.1.6 Geographical Segmentation by Revenue 2013
19.1.7 Business Strategy
18.1.8 Recent Developments
18.1.9 SWOT Analysis
18.2 Elelixis Diagnostics SA
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Product Portfolio by Revenue 2013
18.1.5 Business Segmentation by Revenue 2012 and 2013
19.2.6 Geographical Segmentation by Revenue 2013
18.2.7 Business Strategy
18.2.8 Recent Developments
18.2.9 SWOT Analysis
18.3 Halotech DNA SL
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2013
18.3.4 Product Portfolio by Revenue 2013
18.3.5 Business Segmentation by Revenue 2012 and 2013
18.3.6 Geographical Segmentation by Revenue 2013
18.3.7 Business Strategy
18.3.8 Recent Developments
18.3.9 SWOT Analysis
18.4 Medical Electronic Systems LLC
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 Business Segmentation by Revenue 2013
18.4.4 Product Portfolio by Revenue 2013
18.4.5 Business Segmentation by Revenue 2012 and 2013
18.4.6 Geographical Segmentation by Revenue 2013
18.4.7 Business Strategy
18.4.8 Recent Developments
18.4.9 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Causes of Male Infertility
Exhibit 3: Factors Affecting Male Infertility
Exhibit 4: Treatment of Male Infertility
Exhibit 5: Diagnosis of Male Infertility
Exhibit 6: Male Sperm
Exhibit 7: Global Male Infertility Market 2014-2019 (US$ million)
Exhibit 8: Global Male Infertility Market Segmentation by Technology
Exhibit 9: Global Male Infertility Market by Geographical Segmentation 2014
Exhibit 10: Male Infertility Market in Americas 2014-2018 (US$ million)
Exhibit 11: Male Infertility Market in the EMEA Region 2014-2019 (US$ million)
Exhibit 12: Male Infertility Market in the APAC Region 2014-2019 (US$ million)
Exhibit 13: Medications associated with Male Infertility
Exhibit 14: Occupational and Lifestyle factors affecting Human Male Sperm
Exhibit 15: CooperSurgical Inc.: Business Segmentation by Revenue 2013
Exhibit 16: CooperSurgical Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 17: CooperSurgical Inc.: Sales by Geography 2013
Exhibit 18: Elelixis Diagnostics SA: Business Segmentation by Revenue 2013
Exhibit 19: Elelixis Diagnostics SA: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 20: Elelixis Diagnostics SA: Sales by Geography 2013
Exhibit 21: Halotech DNA SL: Business Segmentation by Revenue 2013
Exhibit 22: Halotech DNA SL: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 23: Halotech DNA SL: Sales by Geography 2013
Exhibit 24: Medical Electronic Systems LLC: Business Segmentation by Revenue 2013
Exhibit 25: Medical Electronic Systems LLC: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Medical Electronic Systems LLC: Sales by Geography 2013
